-transparent.png){kind=logo}
BACKGROUND Serotonin antagonists have been proven antisecretory in cholera toxin (CT)-induced hypersecretion in the small intestine of rodents. The pig small intestine is a good model for the human small intestine with regard to physiologic and pharmacologic processes. METHODS The antisecretory effect of intraluminally administered methysergide, renzapride, ketanserin, granisetron, and tropisetron on CT-induced hypersecretion was tested in isolated pig jejunal loops in vivo. RESULTS Methysergide, ketanserin, and granisetron reduced the hypersecretory effect of CT maximally by 25%, 80%, and 50%, respectively. Tropisetron enhanced whereas renzapride did not alter the CT response. Combination of ketanserin and granisetron gave a maximal inhibitory effect of about 85%. Surprisingly, renzapride, granisetron, and tropisetron each induced hypersecretion. Taking into account the hypersecretory effect of the antagonists, they all reduced this CT-elicited hypersecretion. CONCLUSIONS Results suggest involvement of the 5-hydroxytryptamine-2 and 5-hydroxytryptamine-3 receptor subtypes as mediators in CT-induced hypersecretion in pig jejunum, and antidiarrheal therapeutic potentials of ketanserin and granisetron.
M B Hansen, and
E Skadhauge
February 1995,
Pharmacology & toxicology,
M B Hansen, and
E Skadhauge
June 1977,
Medical biology,
M B Hansen, and
E Skadhauge
May 1997,
Lancet (London, England),
M B Hansen, and
E Skadhauge
August 1992,
Japanese journal of medical science & biology,
M B Hansen, and
E Skadhauge
January 2009,
Gastroenterology,
M B Hansen, and
E Skadhauge
April 1982,
Acta pharmacologica et toxicologica,
M B Hansen, and
E Skadhauge
August 1983,
Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology,
M B Hansen, and
E Skadhauge
September 1997,
European journal of gastroenterology & hepatology,
M B Hansen, and
E Skadhauge
January 2017,
Frontiers in physiology,
